MOR.F - MorphoSys AG

Frankfurt - Frankfurt Delayed price. Currency in EUR
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
71,755
71,755
76,443
66,791
49,744
Cost of revenue
12,085
12,085
1,797
33
97
Gross profit
59,670
59,670
74,646
66,758
49,647
Operating expenses
Research development
108,432
108,432
106,397
116,809
95,723
Selling general and administrative
59,336
59,336
28,310
12,315
9,521
Total operating expenses
167,768
167,768
134,786
134,409
109,547
Operating income or loss
-108,098
-108,098
-60,140
-67,651
-59,901
Interest expense
2,272
2,272
179
374
20
Total other income/expenses net
1,050
1,050
-202
-961
-925
Income before tax
-106,520
-106,520
-60,476
-68,791
-59,864
Income tax expense
-3,506
-3,506
-4,305
1,036
519
Income from continuing operations
-103,014
-103,014
-56,172
-69,827
-60,382
Net income
-103,014
-103,014
-56,172
-69,826
-60,383
Net income available to common shareholders
-103,014
-103,014
-56,172
-69,826
-60,383
Basic EPS
-
-3.26
-1.79
-2.41
-2.28
Diluted EPS
-
-3.26
-1.79
-2.41
-2.28
Basic average shares
-
31,611
31,339
28,948
26,443
Diluted average shares
-
31,611
31,339
28,948
26,543
EBITDA
-
-98,003
-56,547
-64,388
-56,080
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more